Endeavor BioMedicines
Pushing Boundaries to Change Lives
San Diego, United States · Founded 2019
- Headquarters
- San Diego
- Founded
- 2019
- Business Model
- B2B
- Website
- endeavorbiomedicines.com
About
Endeavor BioMedicines is a clinical-stage biotechnology company headquartered in San Diego that develops transformational medicines for patients with life-threatening and intractable diseases. Co-founded by CEO John Hood, PhD, the company's lead pipeline targets fibrotic lung disease, including Taladegib (ENV-101), which aims to reverse rather than merely slow disease progression and has received PRIME designation from the European Medicines Agency. Endeavor has raised financing including a $132.5 million oversubscribed Series C round to advance its pipeline.
Summary
Endeavor BioMedicines is a Biotech company based in San Diego, United States, founded in 2019.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.